# Dairy Cattle Bacterial Outbreaks: Pathogens and Management
## Key Takeaways
- Bovine mastitis, primarily caused by contagious (*Staphylococcus aureus*) and environmental (*Escherichia coli*, *Streptococcus uberis*) pathogens, remains the most economically significant infectious disease, with antimicrobial resistance generally low in North America and Europe but with emerging multidrug-resistant strains like hypermucoviscous *Klebsiella pneumoniae*.
- Bovine Respiratory Disease Complex (BRD) is a multifactorial syndrome involving *Mannheimia haemolytica*, *Pasteurella multocida*, *Histophilus somni*, and *Mycoplasma bovis*, with significant antimicrobial nonsusceptibility observed for tetracyclines and penicillins in *P. multocida* and *M. haemolytica*, and *M. bovis* posing a growing threat of chronic pneumonia and arthritis.
- Enteric and zoonotic pathogens such as *Salmonella enterica* serovars (especially *S. Dublin*), Shiga toxin-producing *E. coli* (STEC), *Campylobacter jejuni*, and *Listeria monocytogenes* pose risks to herd health, production, and public health, with farm-level biosecurity being critical for controlling *S. Dublin* and manure management for *L. monocytogenes*.
- Bacterial reproductive tract infections, caused by pathogens like *Trueperella pyogenes* and *E. coli*, contribute to infertility, while emerging zoonotic diseases such as brucellosis (*Brucella abortus*) and Q fever (*Coxiella burnetii*) necessitate stringent control measures including vaccination and biosecurity.
- Diagnostic approaches range from conventional culture and antimicrobial susceptibility testing (AST) to molecular methods like multiplex PCR and whole genome sequencing (WGS), with serology vital for herd-level screening of zoonotic infections.
- Prevention and control strategies integrate robust biosecurity, targeted vaccination protocols, rigorous hygiene, and judicious antimicrobial stewardship, including selective treatment protocols for clinical mastitis and dry cow therapy, alongside exploration of alternative therapies like probiotics and phage therapy.
---
## 1. Introduction
Bacterial outbreaks in dairy cattle represent a persistent threat to herd health, milk production, and economic sustainability. The etiological landscape encompasses a diverse array of Gram-positive and Gram-negative organisms that can cause clinical syndromes affecting the mammary gland, respiratory tract, gastrointestinal system, reproductive organs, and systemic circulation [1, 2, 3]. Understanding the epidemiology, pathogenesis, and management of these outbreaks is critical for veterinarians, diagnosticians, and herd managers. This article synthesizes current knowledge on major bacterial pathogens involved in dairy cattle outbreaks, with emphasis on recent surveillance data, antimicrobial susceptibility patterns, and evidence-based control measures.
## 2. Major Bacterial Syndromes in Dairy Cattle
### 2.1 Bovine Mastitis
Mastitis remains the most economically burdensome infectious disease in dairy production worldwide [4]. The condition is characterized by inflammation of the mammary gland, most commonly triggered by bacterial intramammary infection (IMI). Pathogens are broadly categorized as contagious (e.g., *Staphylococcus aureus*, *Streptococcus agalactiae*) or environmental (e.g., *Escherichia coli*, *Streptococcus uberis*, *Klebsiella pneumoniae*) [5].
**Key mastitis pathogens and their epidemiological features:**
| Pathogen | Category | Clinical Presentation | Antimicrobial Resistance Trends |
|-----|-----|-----------|-----------------|
| *Staphylococcus aureus* | Contagious | Clinical and subclinical; often chronic | Low resistance; 0.7% erythromycin resistance in North America (2011-2022) [1] |
| *Streptococcus uberis* | Environmental | Clinical mastitis; variable severity | Low ampicillin resistance (0%); moderate pirlimycin resistance (18.4%) [1] |
| *Streptococcus dysgalactiae* | Contagious/environmental | Clinical and subclinical | Very low ceftiofur resistance (0.1%) [1] |
| *Escherichia coli* | Environmental | Acute clinical mastitis; may cause systemic signs | Low ceftiofur resistance (2.8%); moderate ampicillin resistance (9.2%) [1] |
| *Klebsiella pneumoniae* | Environmental | Severe clinical mastitis; poor cure rates | Highly sensitive to enrofloxacin (100%) in Chinese isolates [6] |
| *Non-aureus staphylococci* | Opportunistic | Subclinical most common | Higher penicillin resistance (34% in Norway) [5] |
Large-scale surveillance studies have demonstrated that antimicrobial resistance among mastitis pathogens remains relatively low in North America and Europe, although geographical variations exist [1, 5]. In Norway, *S. aureus* was the most frequently isolated pathogen (27.1% of clinical mastitis samples), and only 2.5% of isolates were resistant to benzylpenicillin [5]. Similarly, a 12-year North American study (2011-2022) found that resistance to commonly used antimicrobials did not increase substantially [1].
The emergence of multidrug-resistant (MDR) strains, particularly among *K. pneumoniae* and *S. aureus*, is a growing concern. In Chinese dairy farms, 35.9% of clinical mastitis cases were attributed to *K. pneumoniae*, with 94.44% of isolates from one farm displaying a hypermucoviscous phenotype associated with the *rmpA* virulence gene [6]. Genotypic profiling of staphylococci and streptococci from the Philippines revealed that 28% of staphylococcal and 12.2% of streptococcal isolates were MDR, harboring resistance genes such as *mecA*, *blaSPM-1*, and *tetB* [7].
### 2.2 Bovine Respiratory Disease Complex
Bovine respiratory disease (BRD) is a multifactorial syndrome with significant bacterial involvement [3, 8]. The bacterial component of BRD typically involves *[Mannheimia haemolytica](/knowledge/bacteria/livestock-bacteria/mannheimia-haemolytica)*, *Pasteurella multocida*, *[Histophilus somni](/knowledge/bacteria/livestock-bacteria/histophilus-somni-bovine-thrombotic-meningoencephalitis-brd)*, and *[Mycoplasma bovis](/knowledge/bacteria/livestock-bacteria/mycoplasma-bovis)* [8, 9]. These pathogens often act in concert with viral agents such as [bovine respiratory syncytial virus](/knowledge/viruses/livestock-viruses/bovine-respiratory-syncytial-virus) (BRSV) and [bovine viral diarrhea virus](/knowledge/viruses/livestock-viruses/bovine-viral-diarrhea-virus) (BVDV).
**Antimicrobial susceptibility patterns of BRD pathogens:**
| Pathogen | Notable Nonsusceptibility | Age-Associated Risk |
|-----|--------------|-----------|
| *Pasteurella multocida* | Tetracycline (74%), spectinomycin (46%) | Calves show highest odds of nonsusceptibility [9] |
| *[Mannheimia haemolytica](/knowledge/bacteria/livestock-bacteria/mannheimia-haemolytica)* | Penicillin (43%), tetracycline (34%) | Heifers show greatest odds compared to cows [9] |
| *[Histophilus somni](/knowledge/bacteria/livestock-bacteria/histophilus-somni-feedlot-cattle-pathogenesis-diagnostic-detection)* | Variable; often co-isolated with other pathogens | Commonly detected in fatal pneumonia outbreaks [8] |
| *[Mycoplasma bovis](/knowledge/bacteria/livestock-bacteria/mycoplasma-bovis)* | Intrinsically resistant to beta-lactams; susceptibility to tetracyclines variable | High-risk calves more likely to carry integrative conjugative elements associated with resistance |
A repeated cross-sectional study in California dairy farms demonstrated that farm-level effects and age group significantly influenced the odds of nonsusceptible isolates [9]. For *P. multocida*, calves had significantly greater odds of tetracycline and spectinomycin nonsusceptibility than cows [9]. Metagenomic analysis of the nasopharyngeal microbiome revealed that BRD is associated with distinct microbial community patterns rather than a single pathogen, and that BRD cases harbor more unique antimicrobial resistance genes than controls.
*Mycoplasma bovis* is increasingly recognized as a primary cause of chronic pneumonia and arthritis in dairy calves and heifers [8]. In Italian dairy herds, *M. bovis* was detected in 16.2% of fatal pneumonia cases, and outbreaks displayed a seasonal pattern with peaks in April and September [8]. Transmission dynamics within herds are complex, with cow-to-calf and calf-to-calf pathways being significant contributors to spread. Biocontainment measures, including revision of colostrum and milk feeding practices, have been shown to reduce morbidity from 80% to 3% in affected pre-weaning calves.
### 2.3 Enteric and Zoonotic Pathogens
Enteric bacterial infections in dairy cattle can cause significant production losses and pose zoonotic risks. Key pathogens include *Salmonella enterica* serovars (particularly S. Dublin and S. Typhimurium), *Escherichia coli* (including Shiga toxin-producing strains, STEC), *Campylobacter jejuni*, and *[Listeria monocytogenes](/knowledge/bacteria/livestock-bacteria/listeria-monocytogenes-circling-disease-ruminants-silage)* [10, 11, 12].
**Salmonella Dublin** has emerged as a major cause of disease in dairy cattle, especially in North America. A retrospective analysis of postmortem cases in British Columbia found that over half of S. Dublin cases presented with respiratory symptoms, and calves were 38 times more likely to have S. Dublin than adults [12]. Farm-level management practices explained 92% of the variance in S. Dublin infection risk, highlighting the importance of biosecurity [12]. Multidrug-resistant strains of S. Dublin have been reported [12].
**Shiga toxin-producing *E. coli*** (STEC), particularly serotype O157:H7, is carried asymptomatically by cattle but can cause severe foodborne illness in humans. A meta-analysis of U.S. studies reported a pooled prevalence of 1.5% in dairy cattle, with hide and carcass prevalences of 54.7% and 21.3%, respectively. Calves are more likely to shed STEC, and group housing during weaning increases prevalence. Environmental contamination from manure is a primary route of transmission to produce and water sources.
**[Listeria monocytogenes](/knowledge/bacteria/livestock-bacteria/listeria-monocytogenes-circling-disease-ruminants-silage)** is an opportunistic pathogen found in farm environments, capable of causing encephalitis and abortion in cattle and severe illness in humans [11]. A study of Spanish dairy farms found a high incidence of L. monocytogenes in manure, with 89% of isolates belonging to serogroup IVb, which includes strains responsible for human listeriosis outbreaks [11]. Effective manure management is essential to prevent recirculation of this pathogen within the farm [11].
**Campylobacter** species, particularly *C. jejuni*, are common in dairy cattle and can contaminate milk. Studies have identified that dairy herds colonized by *Campylobacter* have distinct intestinal bacterial populations compared to non-colonized herds [13]. The [zoonotic risk](/knowledge/parasites/pet-parasites/zoonotic-risk-humans-get-parasites-from-pets) from unpasteurized dairy products remains significant.
### 2.4 Reproductive and Emerging Pathogens
Bacterial reproductive tract infections are a major cause of infertility and economic loss in dairy herds. Common pathogens include *[Trueperella pyogenes](/knowledge/bacteria/livestock-bacteria/trueperella-pyogenes)*, *Escherichia coli*, *Fusobacterium necrophorum*, *Clostridium tertium*, and *[Histophilus somni](/knowledge/bacteria/livestock-bacteria/histophilus-somni-bovine-thrombotic-meningoencephalitis-brd)* [14]. A study in India reported a 10.44% prevalence of uterine infections, with subclinical endometritis accounting for 60.8% of cases [14]. A multiplex PCR assay targeting *E. coli*, *C. tertium*, and *H. somni* demonstrated high diagnostic efficiency (sensitivity 80-100%) for detecting these pathogens [14].
**Brucellosis** caused by *Brucella abortus* (and occasionally *B. melitensis*) is a notifiable zoonotic disease that causes abortion and reproductive failure. In Spain, an outbreak of *B. melitensis* in dairy cattle was managed through test-and-slaughter and vaccination. In Africa, brucellosis seroprevalence varies widely (0-40%), and risk factors include herd size, animal movements, and poor biosecurity.
**Q fever**, caused by *Coxiella burnetii*, is increasingly recognized as a cause of abortion and stillbirth in dairy cattle. A Scottish study found that 78.6% of pre-calving heifers were seropositive, and bacterial loads were highest in post-calving animals, suggesting that pregnancy stage influences shedding [15]. In Cameroon, *C. burnetii* seroprevalence in pastoral cattle was 12.4-14.6% [10]. Management of Q fever involves vaccination (where licensed), biosecurity, and rodent control.
**Caseous lymphadenitis** caused by *Corynebacterium pseudotuberculosis* is classically a disease of small ruminants, but an outbreak in a Portuguese dairy herd of 500 Friesian cows demonstrated that cattle can be affected. The outbreak was likely facilitated by proximity to infected goats and poor biosecurity, and an autogenous vaccine was developed for control [16].
## 3. Antimicrobial Resistance and Stewardship
Antimicrobial resistance (AMR) in dairy cattle pathogens is a growing concern, driven by antimicrobial use (AMU) for prophylaxis and treatment [4]. However, comprehensive surveillance data indicate that resistance levels remain relatively low for many mastitis pathogens in North America and Europe [1, 5]. A 12-year study of 10,890 isolates from 29 veterinary laboratories found no substantial increase in resistance to common drugs such as ceftiofur, pirlimycin, and erythromycin [1].
In contrast, resistance in BRD pathogens is more pronounced. *P. multocida* and *M. haemolytica* show high levels of nonsusceptibility to tetracyclines and penicillins, with significant farm-to-farm variability [9]. Integrative and conjugative elements (ICE) in *M. bovis* facilitate horizontal transfer of resistance genes, and high-risk calves are more likely to harbor ICE-positive strains.
Selective treatment protocols for clinical mastitis and dry cow therapy are gaining acceptance as tools to reduce AMU without compromising udder health [2]. Rapid on-farm diagnostics, such as culture and sensitivity or molecular assays, enable targeted therapy. A review of selective clinical mastitis treatment concluded that no economic losses or animal welfare issues are expected when adopting selective versus blanket therapy [2].
Farm-level management practices are key drivers of AMR. A survey of Tennessee dairy producers found that only 9.1% were very concerned about AMR, and 18.6% never used culture and sensitivity testing. The veterinarian was identified as the most trusted source of information on prudent AMU. Implementation of good management practices, vaccination, and the use of immunomodulatory products are considered viable alternatives to antimicrobials.
## 4. Diagnostic Approaches
Accurate and timely diagnosis is essential for outbreak management. Conventional bacterial culture remains the gold standard for mastitis and BRD diagnosis, but molecular methods offer faster turnaround and higher sensitivity [14].
**Key diagnostic modalities:**
- **Conventional culture and antimicrobial susceptibility testing (AST):** Essential for identifying pathogens and guiding treatment. Broth microdilution is the standard method for AST in veterinary microbiology [1, 9].
- **Polymerase chain reaction (PCR):** Multiplex PCR panels enable simultaneous detection of multiple pathogens from a single sample. Examples include assays for mastitis pathogens, BRD agents, and uterine pathogens [14].
- **Quantitative PCR (qPCR):** Used for quantification of bacterial loads, particularly for BRD pathogens in nasal swabs and bronchoalveolar lavage fluid.
- **Whole genome sequencing (WGS):** Provides detailed information on virulence genes, resistance determinants, and phylogenetic relationships. Increasingly used for outbreak investigations [6].
- **Serology:** ELISA-based tests are valuable for herd-level screening of chronic or zoonotic infections such as brucellosis, Q fever, and leptospirosis [10, 15].
- **Point-of-care tests:** Rapid immunochromatographic dip strips (e.g., for staphylococcal mastitis) offer on-site detection within 20 minutes, though sensitivity may be limited to high bacterial loads.
**Mermaid diagram: Decision tree for outbreak investigation and management**
```mermaid
flowchart TD
A["Clinical outbreak suspected"] --> B{"Identify syndrome"}
B -->|"Mastitis"| C["Collect milk samples aseptically"]
B -->|"Respiratory"| D["Collect nasal swabs / BAL"]
B -->|"Enteric"| E["Collect feces / blood"]
B -->|"Reproductive"| F["Collect vaginal swabs / fetal tissues"]
C --> G["Perform culture + AST or PCR panel"]
D --> G
E --> G
F --> G
G --> H{"Pathogen identified?"}
H -->|"Yes"| I["Determine antimicrobial susceptibility"]
H -->|"No"| J["Consider viral / parasitic / non-infectious causes"]
I --> K{"Resistance profile available?"}
K -->|"Yes"| L["Select targeted therapy"]
K -->|"No"| M["Use empirical therapy based on local antibiogram"]
L --> N["Implement treatment and biosecurity measures"]
M --> N
N --> O["Monitor clinical response and re-test if needed"]
O --> P["Review management practices"]
P --> Q["Adjust prevention protocols: vaccination, hygiene, culling"]
```
Biosafety considerations are paramount when handling samples from suspect zoonotic pathogens such as *Brucella* spp., *C. burnetii*, and *Salmonella* spp. Laboratories should follow biosafety level 2 or 3 protocols as appropriate.
## 5. Prevention and Control Strategies
Prevention of bacterial outbreaks in dairy herds requires a multi-layered approach focusing on biosecurity, vaccination, hygiene, and prudent antimicrobial use [3].
### 5.1 Biosecurity and Management
External biosecurity measures include quarantine of new arrivals, screening for pathogens such as *M. bovis* and *Salmonella* Dublin, and controlling visitor and vehicle access. Internal biosecurity involves separating age groups, using dedicated equipment for different barns, and implementing all-in/all-out policies where possible.
For mastitis control, the "five-point plan" remains relevant: post-milking teat disinfection, dry cow therapy, prompt treatment of clinical cases, culling of chronically infected cows, and regular milking machine maintenance. The use of teat sealants and selective dry cow therapy can reduce AMU while maintaining udder health.
### 5.2 Vaccination
Vaccines are available for several key pathogens, though efficacy varies. Autogenous vaccines have been used successfully in specific outbreaks, such as caseous lymphadenitis in dairy cattle [16]. Commercial vaccines against *S. uberis* mastitis have shown promise in experimental challenge models, reducing clinical signs and bacterial shedding. Vaccination against BRD pathogens (e.g., *M. haemolytica*, *P. multocida*, *H. somni*) is common in high-risk calves, though the efficacy of multivalent vaccines is sometimes limited by strain diversity [3].
For zoonotic pathogens, vaccination is a critical component of control. *Brucella abortus* strain RB51 vaccine is widely used in endemic areas, and *Coxiella burnetii* phase I vaccines are licensed in some countries.
### 5.3 Alternative and Complementary Strategies
Alternatives to antimicrobials are being actively researched. Probiotics and immunobiotics have been shown to modulate mammary gland immunity and reduce the severity of mastitis. Phytochemicals, including essential oils and plant extracts, exhibit antibacterial activity against mastitis pathogens. Chitosan, particularly in combination with essential oils, demonstrated potent antibacterial effects against *S. agalactiae* and *S. uberis*. Biogenic silver nanoparticles have shown efficacy against multidrug-resistant *Salmonella* Typhimurium from dairy calves. Phage therapy targeting mastitis-causing *Staphylococcus aureus* and *E. coli* is under investigation, with promising results against biofilm-forming strains.
## 6. Conclusions
Bacterial outbreaks in dairy cattle remain a major challenge to the industry. The pathogen landscape is diverse and evolving, with emerging threats such as *M. bovis*, *S. Dublin*, and hypermucoviscous *K. pneumoniae* requiring heightened surveillance. Antimicrobial resistance, while still relatively low in many mastitis pathogens, is more pronounced in BRD-associated bacteria and is driven by farm-level management practices. Selective treatment protocols, rapid diagnostics, and improved biosecurity offer practical solutions to reduce antimicrobial use without compromising animal health. Future research should focus on developing effective vaccines, exploring alternative therapies, and implementing robust surveillance systems to detect emerging resistance trends.
***
## Related Clinical & Scientific Guides
* [Duck Diseases: A Comprehensive Overview for Veterinary Practitioners](/knowledge/bacteria/general/duck-diseases-comprehensive-overview-veterinary)
* [Salmonella Dublin in Cattle: Emerging Pathogen, Diagnostic Challenges, and Public Health Impact](/knowledge/bacteria/general/salmonella-dublin-cattle-emerging-pathogen-diagnostic-public-health)
* [Mycoplasma Infections in Poultry: Vaccination Strategies and Control Programs](/knowledge/bacteria/general/mycoplasma-infections-in-poultry-vaccination-strategies-and-control-programs)